




Training persons with early-stage Alzheimer’s disease how to use 1 
an electronic medication management device: Development of an 2 
intervention protocol  3 
ABSTRACT  4 
Background/objectives: Medication management is challenging for persons with 5 
Alzheimer's disease (AD) and their caregivers. Electronic medication management 6 
devices (eMMDs) are specifically designed to support this task. However, theory-driven 7 
interventions for eMMD training with this population are rarely described. This study 8 
aimed to develop and assess the appropriateness of an intervention protocol to train 9 
persons with early-stage AD how to use an eMMD. 10 
Methods: Interviews with three categories of participants [persons with early-stage AD 11 
(n=3), caregivers (n=3) and clinicians (n=3)] were conducted to understand medication 12 
management needs, perceived usefulness of an eMMD, and to explore training strategies. 13 
Subsequently, this knowledge was integrated in an intervention protocol which was 14 
validated with the three clinicians. A content analysis led to iterative modifications to 15 
maximize the acceptability and coherence of the intervention protocol in a homecare 16 
context.  17 
Results: The final intervention protocol specifies the expertise required to provide the 18 
training intervention and the target population, followed by an extensive presentation of 19 
eMMD features. Specific learning strategies tailored to the cognitive profile of persons 20 
with AD with step-by-step instructions for clinicians are included. Finally, it presents 21 
theoretical information on cognitive impairment in AD and how eMMDs can support 22 





Conclusions: This intervention protocol with its theoretical and pragmatic foundation is 24 
an important starting point to enable persons with early-stage AD to become active users 25 
of eMMDs. Next steps should evaluate the immediate and long-term impacts of its 26 
implementation on medication management in the daily lives of persons with AD and 27 
their caregivers.  28 
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INTRODUCTION 32 
Alzheimer’s disease (AD) is characterized by progressive impairment of memory and 33 
other mental functions affecting the execution of activities of daily living (McKhann et 34 
al., 1984; Weintraub et al, 2012). Difficulties experienced by persons with AD include 35 
medication management, which is also one of the main domains of care supported by 36 
family caregivers in the home environment (Brodaty & Green, 2002; Fortinsky, 2001; 37 
Gillespie et al., 2014; While et al., 2013). More than 54% of caregivers of people with 38 
dementia support medication management (Gillespie et al., 2014). Managing medication 39 
is complex and involves several tasks, such as handling and differentiating between 40 
multiple pills, following specific schedules, identifying side effects, and managing 41 
prescriptions. This role is crucial considering that medication non-adherence can have 42 
serious consequences, including poor health outcomes, unnecessary diagnostic and 43 
therapeutic measures, hospitalizations, and admission to a nursing home (Col et al., 1990; 44 





many challenges that make their role difficult (Gillespie et al., 2014). Caregivers need to 46 
manage a  high and varying number of daily medication intakes and prescription duration 47 
(Smith et al., 2003; While et al., 2013). They also have to develop their own strategies to 48 
remember when to give a specific medication with limited indications on the pill bottles 49 
and not a lot more from the prescriber (Gillespie et al., 2014). The lack of support and the 50 
complexity of the task may easily lead to burden for family caregivers (Poland et al., 51 
2014). 52 
 53 
People with dementia have a strong desire to maintain independence in their daily 54 
activities in order to stay at home as long as possible (Roger, 2008). Technologies, in 55 
particular eMMDs, have the potential to increase the independence of individuals with 56 
cognitive impairments and reduce the assistance needed from caregivers. Indeed, eMMDs 57 
are designed to support basic operations such as classifying pills, issuing reminders when 58 
to take the medication, providing cues to select the right medication in the pill box, and 59 
remotely tracking medication adherence (Paterson et al., 2017). Despite their relevance, 60 
the use of eMMDs by individuals with cognitive impairments and their family caregivers 61 
has not received much attention in the literature. 62 
 63 
Several studies suggest that individuals in the early stages of AD can learn/relearn various 64 
daily life activities if appropriate methods are used (Clare & Jones, 2008; de Werd et al.,  65 
2013; Thivierge et al., 2008; Wilson et al., 1994). Errorless learning methods are 66 
particularly useful in facilitating learning for persons with AD because they avoid 67 
exposing the person to wrong answers. There are three specific subtypes of errorless 68 





(Baddeley & Wilson, 1994), spaced retrieval (Camp, 1989; Camp et al., 1996)  and 70 
vanishing cues (Glisky et al., 1986). Errorless learning consists of exposing the person 71 
exclusively to the correct answer to avoid eliciting impaired episodic memory. With 72 
spaced retrieval, information is provided to the person who is asked to repeat it 73 
immediately, then again at gradually increasing intervals. Finally, with vanishing cues 74 
method, the assistance offered is gradually reduced by giving less and less informative 75 
cues until the person is completely independent.  A common feature of these methods is 76 
that the correct information can be given verbally or the person is guided physically with 77 
tactile prompts to execute each action in learning a skill (Haskins et al., 2012).  78 
 79 
Various studies have used one or many of these errorless learning methods with persons 80 
with AD to optimize the use of external aids, such as calendars, to-do lists, mobile phones, 81 
electronic organizers, pen-and-paper organizers, radio tapes, and voice messaging 82 
technologies (Bier et al., 2008; Camp et al., 1996; Imbeault et al., 2013; Lekeu et al., 83 
2002; Quittre et al., 2009; Rouleau et al., 2006; Thivierge et al., 2008). These studies 84 
showed that persons with AD can learn how to use external aids to access specific 85 
information. However, none of them examined how technologies can support daily life 86 
activities involving several procedural steps such as medication management.  87 
 88 
Implementing assistive technologies in a person’s home environment is complex (Molin 89 
et al., 2007; Robinson et al., 2007; Starkhammar & Nygård, 2008), and most studies 90 
involved caregivers as primary users of technologies (Bartfai & Boman, 2014; Rosenberg 91 
et al., 2012). Currently, there are few studies looking at assistive technologies used by 92 
persons with AD and the interventions used are not detailed. In addition, no studies have 93 





to be addressed are to detail interventions adapted to the cognitive capacities of persons 95 
with AD, and to understand how they can be used to train them in using technologies such 96 
as eMMDs to support their daily life.  97 
The overall objective of this study was thus to develop and assess the appropriateness of 98 
an intervention protocol, incorporating specific learning strategies that engage persons 99 
with early-stage AD and their caregivers in managing medication at home with an 100 
eMMD. In our study, appropriateness refers to the characteristics of the intervention 101 
perceived as being suitable, useful and relevant prior to adoption (Proctor et al., 2011). 102 
METHOD 103 
Study Design 104 
This user-centered development study was informed by a purposive sample representing 105 
the intervention’s potential end users (Dabbs et al., 2009), that is, persons with early-stage 106 
AD, family caregivers and clinicians. The study was carried out in three steps. Step 1 107 
involved all end users and aimed at understanding their needs. Using interviews, it 108 
explored medication management challenges, perceived usefulness of the eMMD, and 109 
perceived usefulness of the errorless training strategies. In Step 2, the eMMD intervention 110 
protocol was developed by our team, based on key considerations evidenced by Step 1 111 
and international standards for reporting interventions (Hoffmann et al., 2014). Step 3 112 
involved the same clinicians as in Step 1 to evaluate the appropriateness of the eMMD 113 
intervention protocol for clinical use. This study was approved by the Ethics Committee 114 







Three participants from each category of end users were recruited, that is, three dyads of 118 
persons with AD and their family caregiver, and three clinicians. The persons with AD 119 
had to be at least 65 years of age, have a problem with medication management and have 120 
been diagnosed with probable early-stage AD. Exclusion criteria were to have another 121 
type of dementia or non-compensated hearing/vision problems or to be known for 122 
problems with drug or alcohol use which can affect mental functions such as memory. 123 
Family caregivers had to provide persons with AD at least four hours of assistance per 124 
week, be directly involved in medication management and not have cognitive disorders 125 
themselves. Persons with AD and their family caregivers were recruited at the cognition 126 
outpatient clinic of the Institut universitaire de gériatrie de Montréal. Clinicians were 127 
occupational therapists with at least 10 years of experience, not related to the persons with 128 
AD and their caregivers. Training on activities of daily living falls within the area of 129 
expertise of these professionals (de Werd et al., 2013; Laver et al., 2017). They were 130 
recruited at three centres providing in-home rehabilitation services for individuals with 131 
cognitive disorders. The participants included two men and one woman (78, 80 and 85 132 
years) who had been diagnosed with early-stage AD, their family caregivers (two women 133 
and one man of respectively 74, 75 and 78 years) and three occupational therapists 134 
(women with 23, 18 and 13 years of practice). 135 
 136 
eMMD description 137 
eMMDs are electronic medication dispensers with a reminder system. The model 138 
presented to the participants included a 28-compartment dispenser (9”x9”) covered by a 139 





Visual cues and audio alarms alert the person when it is time to take the medication and 141 
identify from which compartment it must be taken. All data are uploadable to a secure 142 
Internet server and the system can calculate an adherence ratio (number of pills 143 
taken/number of pills prescribed). In normal use, the pharmacist is responsible for 144 
programming the device and preparing the medication as prescribed by the primary care 145 
physician. Data pertaining to medication management (time of opening, number of 146 
reminders, errors and omissions) can be sent by email or text message to a person 147 
designated by the user (caregiver and/or clinician).  148 
 149 
Development and Assessment of the Intervention Protocol  150 
Understanding end users’ needs (Step 1)  151 
Procedure 152 
The first step involved all end users and aimed to understand their needs and challenges 153 
related to medication management and to explore the appropriateness of the eMMD to 154 
address them. Individual semi-structured interviews were held with persons with AD 155 
separate from their caregivers. Participants saw a videoclip of the features described later 156 
in this section, followed by an offline manipulation of the device. Interviews started with 157 
open-ended general questions about medication management challenges. Then 158 
participants watched a first videoclip showing use of the electronic pill dispenser. They 159 
were invited to handle it and were then asked how the eMMD could help them with 160 
medication management. The last part of the meeting explored their perception of the 161 
errorless training methods with a second videoclip showing a person participating in an 162 





questions explored the participants’ willingness to be involved in such training strategies. 164 
Table 1 shows the interview structure and topics covered, with samples of questions asked 165 
during the interviews. 166 
 167 
Analysis 168 
All interviews were audiotaped and transcribed verbatim followed by a content analysis 169 
(Cavanagh, 1997). Answers to the questions were grouped by interview section and 170 
category of participants (persons with AD, family caregivers and clinicians) by the first 171 
author. Mains ideas were discussed with the co-authors and a summary was written. It 172 
was used as a guide for the development of the intervention protocol. 173 
 174 
(Table 1 here) 175 
 176 
Development of the intervention protocol (Step 2) 177 
The intervention protocol was first structured according to the Template for Intervention 178 
Description and Replication (TIDieR) Checklist and Guide (Hoffmann et al., 2014), to 179 
ensure that all relevant elements were covered. The TIDieR is a 12-item tool for reporting 180 
interventions that can be reliably replicated in clinical practice and assessed in research 181 
trials. Our study used nine of the items, i.e. brief name, why, what (materials), what 182 
(procedures), who provided, how, where, when and how much, and tailoring. Three items 183 
relevant for reporting intervention in studies were not applicable (modifications, how well 184 
the intervention was planned, and how well the intervention was delivered). 185 
 186 
Second, the protocol integrated the evidence gathered at Step 1 as well as theoretical 187 





stage behavioral approach for individuals with cognitive impairment described by 189 
Sohlberg and Mateer ( 1989). The description of the intervention procedures to obtain the 190 
desired behavioural change also integrated errorless learning methods (Baddeley & 191 
Wilson, 1994; Camp et al.,  2000; Fontaine, 1996). The number and intensity of 192 
intervention sessions were estimated by reviewing existing practices using the same 193 
approach with similar populations (Haskins et al., 2012). Specifications concerning the 194 
expertise required to deliver the intervention and disciplinary background were based on 195 
a critical examination of existing interventions conducted with individuals with dementia 196 
(Imbeault et al., 2013; Lancioni et al., 2009; Lekeu et al., 2002; O’Neill et al., 2011; 197 
Oriani et al., 2003; Perilli et al., 2013). This step resulted in the construction of a prototype 198 
of the protocol based on intervention strategies tailored to the cognitive abilities of 199 
persons with AD.  200 
 201 
Perceived appropriateness of the intervention protocol (Step 3) 202 
Procedure 203 
This step of the study involved the three clinicians and used an iterative process. The 204 
clinicians received the experimental version of the intervention protocol by email and 205 
were asked to review it for content and structure and to evaluate how it could be used in 206 
their daily practice based on the demonstrations in the videoclips. They were encouraged 207 
to test it with colleagues or clients without further training. A month later, the clinicians 208 






The first author produced a synthesis of each interview to capture the main ideas related 211 
to the intervention protocol’s content and structure. The modifications requested by the 212 
clinicians were identified and used to build the second version of the intervention 213 
protocol. The second version of the protocol was then resubmitted to the clinicians by 214 
email to ensure that the changes made reflected the desired modifications. The clinicians 215 
were then asked to send their written comments and suggestions, which were also 216 
discussed on the phone to make sure their meaning was understood. A second series of 217 
modifications was made to produce the final version of the intervention protocol, which 218 
was unanimously approved after the clinicians read it for the third time with no other 219 
suggestions from the clinicians. 220 
RESULTS 221 
Understanding end users’ needs  222 
Understanding end users’ needs involved exploring how the tasks were currently 223 
performed, perceptions about the new technology and, by extension, perceptions related 224 
to learning how to use the new technology (Dabbs et al., 2009). A variety of medication 225 
management challenges and compensatory strategies were mentioned as we explored how 226 
the tasks were currently performed. Three medication management challenges were 227 
consistently named by clinicians and caregivers: difficulty remembering “when”, “which 228 
medication” to take, and “whether or not” it had actually been taken. Persons with AD, 229 
on the other hand, reported that apart from some rare omissions, taking their medication 230 
was not challenging. This was well illustrated by the first person with AD interviewed: 231 
“Hmmm… my husband is annoying, he’s always checking up on me for no reason, 232 





included verbal reminders and standard pill dispensers. Additional strategies described 234 
by clinicians were task adaptation (establishing regular routines) and provision of external 235 
support (calendars, written reminders, and repetition of information by caregivers).  236 
 237 
When we explored the participants’ perceptions of the eMMD, a number of advantages 238 
and disadvantages were raised. Both clinicians and family caregivers said the eMMD had 239 
interesting potential to compensate for difficulties with managing medication. Among its 240 
functionalities, the alarm was identified as the main advantage since it reminds persons 241 
with AD to take their medication, a responsibility normally assumed by family caregivers. 242 
The caregivers realized that the alarm would allow them to go out more since the reminder 243 
would go off in their absence. The second caregiver said: “when I go to my woodlot, I’m 244 
always limited in time, with this device, I could leave for a lot longer.” Clinicians viewed 245 
the alarm as a way to relieve family caregivers of some of the stress related to medication 246 
management since they could leave to the pill dispenser the task of reminding the person. 247 
The second clinician mentioned: “This alarm is even better than human memory!” In 248 
addition, the green light was considered a convenient way to identify which compartment 249 
to open.  250 
 251 
Clinicians and family caregivers both liked the option of receiving data remotely because 252 
of the freedom it could give these caregivers. For their part, persons with AD identified 253 
some options as convenient without further elaboration. However, all the participants 254 
thought the size of the technology was a weakness since no one could imagine taking a 255 
device of that size outside the home. Furthermore, all the clinicians wondered about the 256 





commonly prescribed for persons with AD. In short, the various alerts were appreciated 258 
while the size and limited pharmaceutical forms were disadvantages. 259 
 260 
There was a lot of interest in learning how to use this new technology, particularly the 261 
errorless training methods shown in the videoclips. Family caregivers were relieved to 262 
learn that, by using the right strategies, individuals with AD could still learn. They 263 
envisioned some long-term benefits, making it easier not only to take medication, but also 264 
to learn other routine tasks. This idea was well illustrated by the third caregiver: “It’s 265 
really encouraging to know that he can still learn, I could probably use it to help with 266 
other everyday things”. Being involved full-time with persons with AD, they found the 267 
training provided by a clinician reassuring in helping them with this learning. As for the 268 
three persons with AD, they said they were impressed to know that they could still learn. 269 
One of their reasons for getting involved in this process was the idea of having a weekly 270 
visit. One participant mentioned: “For sure I would love it, having visitors is a welcomed 271 
distraction”. Furthermore, all the clinicians knew that learning was possible despite the 272 
presence of cognitive disorders. However, two of the clinicians had never used errorless 273 
methods since they did not have enough practical knowledge. One concern common to 274 
all three clinicians was the time spent on training. As the second clinicians said: “It’s 275 
really interesting, but I don’t know how feasible it is, because there is never have enough 276 
time to do everything!” In the end, training was viewed favorably by the family 277 
caregivers, persons with AD and clinicians, but obstacles raised included the lack of 278 
know-how and time required. 279 
 280 






The intervention protocol developed at step 2 that was presented to the three clinicians 283 
was divided into two main sections. In the first section, information about AD and its 284 
cognitive impacts, as well as how the disease affects medication management were 285 
presented. The electronic pill dispenser and how it works was also described. In the 286 
second section, the basic principles of errorless learning methods were introduced, 287 
followed by the detailed description of the procedures. The clinicians commented on the 288 
structure and content of this version of the intervention protocol. 289 
Structure 290 
Regarding the structure of the intervention protocol, the clinicians’ wanted to be driven 291 
right into the procedures and have access to the theoretical details at the end of the 292 
intervention protocol as they would only read it as needed. Therefore, they suggested to 293 
move the first section on AD and how it affects medication management to the end. They 294 
also suggested subdividing the content differently with two additional sections. One 295 
focusing specifically on the cognitive profile of individuals with mild AD that could 296 
benefit from this intervention, and the other one describing the eMMD. 297 
  298 
Content 299 
After reading the first version of the intervention protocol, all the clinicians were 300 
delighted with this new intervention protocol but emphasized the need for a more detailed 301 
step-by-step description of the intervention. Indeed, they all considered the description of 302 
the intervention to be crucial. Clinicians were also concerned about the time needed to 303 
assimilate the intervention and be able to integrate it into their practice. A detailed 304 
description would reduce the time and effort needed. They requested more information 305 





how to install the eMMD. They also felt that a synthesis at the end of each section would 307 
be useful. In the theoretical concepts section, they mentioned that having concrete 308 
examples would help them understand complex concepts. All these suggestions were 309 
included in the final version. 310 
 311 
The final intervention protocol version was divided into four main sections. The first 312 
section describes the skills required by health professionals to provide the intervention 313 
and the cognitive, physical, sensory and mental characteristics of clients who can benefit 314 
from it. In the second section, the technology features of the eMMD are fully described 315 
along with the complete operating instructions and how to obtain the device. The third 316 
section provides the detailed step-by-step instructions, including decision trees to support 317 
clinicians throughout the training. Finally, the last section provides key concepts about 318 
AD, its cognitive impacts, and how it affects medication management. It demystifies 319 
cognitive impairments of persons with AD and how the functionalities of the eMMD can 320 
support these impairments. Table 2 presents in detail the content and rationale of the final 321 
version of the intervention protocol in relation with each item of the TIDieR. 322 
 323 
(table 2 here) 324 
 325 
DISCUSSION 326 
The overall objective of this study was to understand end users’ needs in order to develop 327 
and validate a detailed intervention protocol incorporating specific learning strategies to 328 
teach persons with early-stage AD how to use an eMMD. The study resulted in the 329 





gap reported in the rehabilitation research literature concerning the lack of specifications 331 
related to interventions (Dijkers et al.,  2014; Fuhrer, 2003; Lenker & Paquet, 2004). 332 
Understanding end users’ needs  333 
Three groups of participants were directly involved in the study. Their perceptions about 334 
medication management and technology varied with the aspects addressed. For example, 335 
clinicians and family caregivers identified the same issues experienced by persons with 336 
AD with respect to remembering and identifying which medication to take. However, the 337 
group of persons with AD did not feel concerned about these aspects. This could be 338 
because denial is a typical symptom found in early-stage AD (Kaasalainen et al., 2011; 339 
Mokhtari et al., 2012). On the other hand, there was a consensus regarding the 340 
functionalities of the eMMD. This result is in line with the study of Cahill et al. (2007), 341 
where the use of the technology was seen as fostering the functional autonomy of the 342 
person with AD and enhancing the family caregiver’s quality of life. Finally, the training 343 
methods for using the eMMD were perceived positively by all three groups of 344 
participants, although they differed with regard to the perceived time to invest in training. 345 
These results diverge from what Thivierge and her team (Thivierge et al.,  2014) reported 346 
on a program aimed at relearning instrumental activities of daily living with people with 347 
mild AD. While in our study, persons with AD and their family caregivers did not see 348 
any disadvantage related to investing the time required to do the training, Thivierge 349 
(2014) found that some eligible candidates rejected the program because of the high 350 
number of assessments and training sessions or because of the length of their study. On 351 
the other hand, the clinicians in our study viewed the time required by the training as a 352 





nationwide survey, 45 health professionals from various disciplines were questioned 354 
about their interest in and the feasibility of using errorless methods with individuals with 355 
dementia; 67% considered these methods too time-consuming (de Werd et al., 2015). The 356 
time that needs to be invested in the intervention to allow persons with AD learn to use 357 
an eMMD will have to be clarified by future studies by examining the number of training 358 
sessions required. Moreover, it would be interesting to explore if the intervention could 359 
be managed by a variety of health care professionals and thus better accommodate to the 360 
reality of professionals' schedules. By applying the intervention by different 361 
professionals, the time to be spent by each might more realistic fit into their overloaded 362 
schedules. For instance, it would be useful to consider how the intervention could be 363 
integrated in a multidisciplinary intervention plan. 364 
Development of the intervention protocol 365 
The method used to develop the intervention protocol should foster adoption by 366 
clinicians. First, development of the intervention used evidence-based knowledge 367 
mobilization principles. The development of the protocol was discussed in a two-way 368 
process with clinicians, who had a direct impact on its content and structure in order to 369 
transform the first theoretical version into a protocol adapted to their clinical reality. 370 
According to Chagnon and Gervais (2011), this iterative process enhances relevance, 371 
applicability and appropriate presentation of the knowledge generated (Chagnon & 372 
Gervais, 2011) and also facilitates management (Proctor et al.,  2013). Involving end users 373 
from the start of knowledge conception maximizes the likelihood of success over the 374 
longer term when implementing the intervention in health professionals’ practice (Dabbs 375 






Next, using the TIDiER ensured that the description of the intervention was detailed 378 
enough to be able to replicate it in clinical practice and to compare across studies 379 
(Hoffmann et al., 2014). This directly meets the need identified by de Werd et al. (2013) 380 
to have access in geriatric practice to studies specifically describing the methods used, 381 
the intensity and duration of training, clients’ pathology, and other factors that could 382 
affect learning. Also, adherence to a detailed intervention protocol is known to improve 383 
the quality and consistency of care (Hubbard et al., 2012). Laver et al. (2017) also noted 384 
that the characteristics of the most effective interventions in dementia care include 385 
symptom- specific training, a client-centered approach and communication strategies 386 
directed at patients and family caregivers. All these elements are covered by TIDieR 387 
criteria. At this time, studies examining the effectiveness of interventions involving the 388 
use of technology by persons with AD have shown variable results (Imbeault et al., 2013; 389 
Lancioni et al., 2009; Lekeu et al., 2002; O’Neill et al., 2011; Oriani et al., 2003; Perilli 390 
et al., 2013). These results can hardly be compared since little detail on the intervention 391 
protocols are provided. A deliverable of our study is a detailed intervention that can be 392 
replicated in clinical practice and thus will allow to compare results from one study to 393 
another. 394 
STRENGTHS AND LIMITATIONS 395 
This study has various strengths. The development of the intervention protocol was based 396 
not only on theoretical concepts, such as learning methods tailored to the cognitive profile 397 
of individuals with cognitive disorders, but also on the perception of various stakeholders 398 





methodological approach, we were able to incorporate practical elements to provide 400 
clinicians with a tailored tool and present the theory in a way that made it meaningful and 401 
was adapted to their clinical reality. In addition, the involvement of persons with AD, as 402 
a group of participants, is innovative. To our knowledge, no previous study directly 403 
involved individuals with dementia at such an early stage in the development of an 404 
intervention. 405 
 406 
As for limitations, the three groups of participants were exposed to simulations with the 407 
eMMD to capture user needs and appropriateness of the intervention protocol. The actual 408 
application of the intervention protocol, in controlled conditions and later on in the in the 409 
real life context of persons with AD are needed to reach a high level of evidence (Schulz 410 
et al., 2015). This will give persons with AD a more concrete view of the usefulness of 411 
the technology in their daily lives and enable them to make a fairer assessment. Finally, 412 
a small number of participants were involved in this first development stage and they 413 
were all from the same area. Nevertheless, answers within the three groups of participants 414 
were generally along the same lines. For future development stages, larger scale studies 415 
with more participants will be needed.  416 
CONCLUSION 417 
eMMDs could potentially address difficulties encountered by persons with AD in 418 
medication management. However, this technology must be associated with training 419 
tailored to their cognitive capacities so they can learn how to use it and incorporate it in 420 
their routine. This study resulted in the development of a structured training intervention 421 





AD to learn how to use technology. It established strong foundations to understand how 423 
persons with AD can incorporate eMMDs in their daily lives. In the next development 424 
stage, future studies will need to use this intervention in a real home rehabilitation context. 425 
Among other things, this will clarify the final elements of the TIDieR related to evaluation 426 
of adherence and fidelity; modifications, how well the intervention was planned, and how 427 
well the intervention was delivered. 428 
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